Literature DB >> 15726601

Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL).

Yasunori Nakagawa1, Maki Hasegawa, Morito Kurata, Kouhei Yamamoto, Shinya Abe, Miori Inoue, Tamiko Takemura, Katsuiku Hirokawa, Kenshi Suzuki, Masanobu Kitagawa.   

Abstract

Inhibitor of apoptosis protein (IAP)-family proteins suppress apoptotic signaling in normal/neoplastic cells in various settings. To determine the apoptosis-resistant mechanism in adult acute mixed lineage leukemia (AMLL) with biphenotypic blasts responsible for resistance against chemotherapy, the expression levels of IAP-family proteins in AMLL bone marrow cells were analyzed by quantitative RT-PCR. The overall expression levels of IAPs were higher than those in control, AML, and ALL cells. A significant difference for the expression of survivin was observed between AMLL and AML (P <0.05), and differences between AMLL and ALL were significant for the expression of survivin (P <0.05), NAIP (P <0.05), and XIAP (P <0.05). These findings suggest that higher expression of various IAPs is associated with the chemotherapy-resistant nature of this specific type of leukemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15726601     DOI: 10.1002/ajh.20285

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

Review 1.  Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.

Authors:  S Fulda
Journal:  Leukemia       Date:  2014-02-03       Impact factor: 11.528

2.  Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

Authors:  Collins A Karikari; Indrajit Roy; Eric Tryggestad; Georg Feldmann; Clemencia Pinilla; Kate Welsh; John C Reed; Elwood P Armour; John Wong; Joseph Herman; Dinesh Rakheja; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2007-03-05       Impact factor: 6.261

3.  Regulation of apoptosis by XIAP ubiquitin-ligase activity.

Authors:  Andrew J Schile; María García-Fernández; Hermann Steller
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

4.  Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population.

Authors:  Xiao-Qian Xu; Jian-Min Wang; Shu-Qing Lü; Li Chen; Jian-Min Yang; Wei-Ping Zhang; Xian-Min Song; Jun Hou; Xiong Ni; Hui-Ying Qiu
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

5.  Repeated recruitment of LTR retrotransposons as promoters by the anti-apoptotic locus NAIP during mammalian evolution.

Authors:  Mark T Romanish; Wynne M Lock; Louie N van de Lagemaat; Catherine A Dunn; Dixie L Mager
Journal:  PLoS Genet       Date:  2006-12-06       Impact factor: 5.917

6.  Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists.

Authors:  Agnieszka Łupicka-Słowik; Mateusz Psurski; Renata Grzywa; Monika Cuprych; Jarosław Ciekot; Waldemar Goldeman; Elżbieta Wojaczyńska; Jacek Wojaczyński; Józef Oleksyszyn; Marcin Sieńczyk
Journal:  Invest New Drugs       Date:  2020-04-08       Impact factor: 3.850

7.  Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer.

Authors:  Jaewon Choi; Yu Kyeong Hwang; Young Jin Choi; Ki Eun Yoo; Jeong Han Kim; Seok Jin Nam; Jung Hyun Yang; Sang Jin Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Young Hyuck Im
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.